AQR Capital Management
PRAX icon

AQR Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

AQR Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9M Buy
58,656
+29,828
+103% +$9.23M 0.01% 1059
2025
Q4 		$8.5M Buy
28,828
+6,924
+32% +$1.29M ﹤0.01% 1290
2025
Q3 		$1.16M Buy
21,904
+7,324
+50% +$355K ﹤0.01% 2339
2025
Q2 		$613K Buy
+14,580
New +$555K ﹤0.01% 2496
2025
Q1 		– Sell
-6,704
Closed -$516K – 3185
2024
Q4 		$516K Sell
6,704
-18,564
-73% -$1.34M ﹤0.01% 2239
2024
Q3 		$1.45M Buy
+25,268
New +$1.36M ﹤0.01% 1656
2023
Q2 		– Sell
-4,973
Closed -$60.3K – 2258
2023
Q1 		$60.3K Sell
4,973
-5,729
-54% -$242K ﹤0.01% 2135
2022
Q4 		$382K Sell
10,702
-6,081
-36% -$190K ﹤0.01% 1907
2022
Q3 		$571K Buy
16,783
+15,623
+1,347% +$778K ﹤0.01% 1728
2022
Q2 		$43K Buy
+1,160
New +$124K ﹤0.01% 2140

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

AQR Capital Management's PRAX Position: Q1 2026 in Review

AQR Capital Management increased its Praxis Precision Medicines (PRAX) stake by 103% in Q1 2026, buying an estimated $9.23M and bringing the position to 58,656 shares worth $18.9M. The position accounts for 0.01% of the portfolio, ranked #1059.

AQR Capital Management first reported a position in PRAX in Q2 2022 and has held it in 10 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • AQR Capital Management held 58,656 shares of Praxis Precision Medicines worth $18.9M as of Q1 2026.
  • AQR Capital Management bought 29,828 Praxis Precision Medicines shares in Q1 2026, an estimated $9.23M.
  • Praxis Precision Medicines made up 0.01% of AQR Capital Management's portfolio in Q1 2026, its #1059 holding.
  • AQR Capital Management first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 10 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.